pioneer 4 semaglutide Dose-response, efficacy, and safety of oral monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial Efficacy, safety and cardiovascular outcomes

160 mg/day for children 7-10 years

(2018) used the current understanding from tendon, ligament and bone and applied this to gastrointestinal tract healing, which could provide a pathway for understanding of the systemic healing capabilities for applications to other tissues

Ueda P, Pasternak B, Eliasson B, Svensson AM, Franzn S, Gudbjrnsdottir S, et al

AARP Hearing Center FDA Approves New Weight Loss Pills People looking to lose or maintain their weight now have new options Key takeaways Two new once-daily GLP-1 weight loss pills won FDA approval, expanding options beyond injections

Refrigeration can help extend the life by an additional week or two, per Purdue

Patients should be counseled that scale weight may not accurately reflect body composition changes